Stay updated with breaking news from Hologic Thinprep. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BD 2025 Strategic Investments Driving Growth and Advancing Innovation; Company Raises Mid-point of Revenue and Adjusted EPS Guidance Ranges Revenue of $4.8 billion increased 1.5% as reported and... | May 4, 2023
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration...
HIV patients with anal high-grade squamous intraepithelial lesions (HSIL) have a lower risk of progression to anal cancer if they receive HSIL treatment.